Amphenol (APH) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
Some insider buying ($1.3M), but sales were much larger ($407M) over the same 12 months.
Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- Next earnings expected around Jan 27, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Richard Adam Norwitt, CEO, President sold 799,576 shares at $82.48 ($65.9M).
- Trade date
- Nov 2, 2026
- Disclosed to the SEC
- Nov 3, 2026
- Type
- Sale (code S)
Read the original SEC filing ↗All APH insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
APH insider transactions (Form 4)
Open-market purchases and sales. 49 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Nov 3SEC | Richard Adam NorwittCEO, President | Sell | 799,5763,855,014 held (−17%) | $82.48 | $65.9M | -14.8% | — |
| Aug 5SEC | Craig A. LampoCFO | Sell | 193,20090,665 held (−68%) | $167.31 | $32.3M | — | — |
| Aug 5SEC | David M. SilvermanEvp, Human Resources | Sell | 120,00015,672 held (−88%) | $174.24 | $20.9M | — | — |
| Aug 5SEC | Lance E. D'AmicoEvp, Secretary & Gencounsel | Sell | 50,00057,065 held (−47%) | $161.99 | $8.1M | — | — |
| Aug 5SEC | Lance E. D'AmicoEvp, Secretary & Gencounsel | Sell | 40,000 | $161.82 | $6.5M | — | — |
| Aug 5SEC | Lance E. D'AmicoEvp, Secretary & Gencounsel | Sell | 10,000 | $161.82 | $1.6M | — | — |
| Aug 3SEC | Richard Adam NorwittCEO, President | Sell | 500,0001,927,507 held (−21%) | $161.57 | $80.8M | — | — |
| Aug 3SEC | Richard Adam NorwittCEO, President | Sell | 186,104864,177 held (−18%) | $162.27 | $30.2M | — | — |
| May 5SEC | Richard Adam NorwittCEO, President | Sell | 61,0721,927,507 held (−3%) | $143.90 | $8.8M | — | — |
| May 5SEC | Richard Adam NorwittCEO, President | Sell | 52,2031,927,507 held (−3%) | $142.04 | $7.4M | — | — |
| May 5SEC | Richard Adam NorwittCEO, President | Sell | 17,5001,927,507 held (−1%) | $143.21 | $2.5M | — | — |
| Feb 19SEC | Craig A. LampoCFO | Sell | 100,000112,110 held (−47%) | $149.98 | $15.0M | — | — |
| Feb 19SEC | Lance E. D'AmicoSee Remarks | Sell | 50,00057,065 held (−47%) | $149.88 | $7.5M | — | — |
| Feb 13SEC | Richard Adam NorwittCEO, President | Sell | 515,2811,927,507 held (−21%) | $147.27 | $75.9M | — | — |
| Feb 13SEC | Richard Adam NorwittCEO, President | Sell | 93,052864,177 held (−10%) | $147.17 | $13.7M | — | — |
| Feb 6SEC | Robert LivingstonDirectorFirst buy in 2 yrsPast buys 2/3 beat S&P | Buy | 10,000135,720 held (+8%) | $128.51 | $1.3M | — | — |
| Dec 2SEC | Peter StraubPresident | Sell | 132,000 | $141.84 | $18.7M | — | — |
| Dec 2SEC | William J. DohertyPresident | Sell | 80,000 | $142.00 | $11.4M | — | — |
| Nov 13SEC | Craig A. LampoCFO | Sell | 258,000167,695 held (−61%) | $143.20 | $36.9M | — | — |
| Nov 13SEC | Craig A. LampoCFO | Sell | 40,07639,884 held (−50%) | $143.50 | $5.8M | — | — |
| Nov 6SEC | Michael R. IvasVp & Corporate Controller | Sell | 120,000152,412 held (−44%) | $140.05 | $16.8M | — | — |
| Nov 3SEC | Michael R. IvasVp & Corporate Controller | Sell | 120,000152,412 held (−44%) | $141.30 | $17.0M | — | — |
| Nov 3SEC | David M. SilvermanSenior Vp, Human Resources | Sell | 120,00012,500 held (−91%) | $141.17 | $16.9M | — | — |
| Oct 30SEC | Lance E. D'AmicoSr. Vp, Secretary & Gencounsel | Sell | 120,00076,400 held (−61%) | $140.01 | $16.8M | — | — |
| Oct 30SEC | William J. DohertyPresident | Sell | 80,000 | $141.04 | $11.3M | — | — |
| Oct 27SEC | Luc WalterPresident | Sell | 212,800433,742 held (−33%) | $134.65 | $28.7M | — | — |
| Oct 27SEC | Luc WalterPresident | Sell | 152,318433,742 held (−26%) | $134.65 | $20.5M | — | — |
Similar past setups: not applicable. There aren't enough comparable past cases for APH's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with APH in the Research Lab
Pre-set to APH's latest insider buy of $10K or more (Feb 6, 2026: Robert Livingston, $1.3M). Tap to change anything.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Amphenol insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $1.3M and 6 sold $407M of APH stock on the open market; P/E 19.3 vs. a sector median of 26.8.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
APH insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $65.9M | 1 |
| Q3 2026 | — | 0 | $180M | 7 |
| Q2 2026 | — | 0 | $18.7M | 3 |
| Q1 2026 | $1.3M | 1 | $112M | 4 |
| Q4 2025 | — | 0 | $201M | 11 |
Valuation, profit and volume
Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 1 Amphenol insider reported open-market purchases totaling $1.3M, while 6 insiders reported sales totaling $407M. 0 of 26 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
APH earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Oct 28, 2026 | -9.3% | None | +4.9%S&P -0.0% | pending |
| Jul 29, 2026 | -7.8% | None | +11.1%S&P +0.1% | -1.3% |
| Apr 29, 2026 | -1.1% | None | +2.5%S&P +1.0% | +1.0% |
| Jan 28, 2026 | +14.6% | None | -10.0%S&P -0.2% | -2.4% |
| Oct 22, 2025 | +0.8% | None | +8.7%S&P +0.1% | -2.7% |
| Jul 23, 2025 | +3.3% | None | +2.6%S&P +0.9% | +4.7% |
| Apr 23, 2025 | +8.0% | None | +15.6%S&P +3.7% | +12.5% |
| Jan 22, 2025 | +2.2% | None | +8.0%S&P +1.1% | -14.0% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
APH short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded APH
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Alan ArmstrongSenate | Bought $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026 | +14.1% |
Insiders at Amphenol
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Richard Adam NorwittCEO, President | — | $285M | Nov 3, 2026 | — | — |
| Craig A. LampoCFO | — | $90.0M | Aug 6, 2026 | — | — |
| Luc WalterPresident | — | $49.2M | Oct 27, 2025 | — | — |
| Lance E. D'AmicoEvp, Secretary & Gencounsel | — | $40.5M | Aug 5, 2026 | — | — |
| David M. SilvermanEvp, Human Resources | — | $37.8M | Aug 5, 2026 | — | — |
| Michael R. IvasVp & Corporate Controller | — | $33.8M | Feb 5, 2026 | — | — |
| William J. DohertyPresident | — | $22.6M | Dec 2, 2025 | — | — |
| Peter StraubPresident | — | $18.7M | Dec 2, 2025 | — | — |
| Robert LivingstonDirector | $1.3M | — | May 27, 2026 | 2 of 3 | — |
| Nancy A. AltobelloDirector | — | — | May 27, 2026 | — | — |
| David P. FalckDirector | — | — | May 27, 2026 | — | — |
| Sanjiv LambaDirector | — | — | May 27, 2026 | — | — |
| Rita S. LaneDirector | — | — | May 27, 2026 | — | — |
| Prahlad R. SinghDirector | — | — | May 27, 2026 | — | — |
| Anne Clarke WolffDirector | — | — | May 27, 2026 | — | — |
| Martin H. LoefflerDirector | — | — | Dec 11, 2025 | — | — |
Board links: companies that share insiders with APH
Directors and executives who filed Form 4s for APH and another company in the last 12 months.
- LINLinde Sanjiv Lamba Director here · CEO, Chair at LIN · latest filing May 27, 2026
- RVTYRevvity Prahlad R. Singh Director here · Please See Remarks at RVTY · latest filing Aug 17, 2026
Insider activity at other Information Technology companies
Same sector, ranked by insider buying in the last 90 days.
APH stock: common questions
Are Amphenol insiders buying APH stock?
In the past 12 months, 1 insider reported open-market purchases of APH worth $1.3M. The latest was Director Robert Livingston bought $1.3M of APH at $128.51 — first open-market purchase in our records.
Are Amphenol insiders selling APH stock?
6 insiders reported sales worth $407M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is APH's P/E ratio?
APH trades at about 19.3 times trailing earnings, compared with a median of 26.8 for the Information Technology sector.
What is APH's 52-week range?
Over the past year APH has traded between $59.39 and $88.62. It last closed at $70.30 on Nov 20, 2026.